A basic research breakthrough by Margarita L. Dubocovich, PhD, reporting the effects of new molecules on circadian rhythms in mice could result in treatments for people affected by jet lag, sleep disorders or even depression.
Research by lead author Steven E. Lipshultz, MD, has revealed that antiretroviral therapy (ART) given to pregnant mothers with HIV puts their exposed but uninfected babies at risk of adverse cardiac events.
The University at Buffalo has been awarded a five-year, $21.7 million Clinical and Translational Science Award (CTSA) from the National Institutes of Health (NIH) to continue Buffalo’s rapid trajectory growing its health care and research sectors.
The Madras Diabetes Research Foundation (MDRF) has named Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of endocrinology, diabetes and metabolism, as the recipient of its 2020 Lifetime Contribution Award.
In the eight months since the University at Buffalo and partners launched the Innovation Hub, seven entrepreneurial teams — including one from the Jacobs School of Medicine and Biomedical Sciences — have received funding from the initiative.
POP Biotechnologies Inc. (POP BIO), a University at Buffalo spinoff, has received a $600,000 contract from the National Institutes of Health to pursue development of a life-saving, life-changing technology: a vaccine against HIV.
Timothy F. Murphy, MD, senior associate dean for clinical and translational research and SUNY Distinguished Professor of medicine, is leading a major initiative addressing health disparities among people living on Buffalo’s East Side.